Research and Markets: Diagnostics Partnering Terms and Agreements

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ns5h26/diagnostics) has announced the addition of the "Diagnostics Partnering Terms and Agreements" report to their offering.

The Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Benefits of this Report:

Diagnostics Partnering Terms and Agreements provides the reader with the following key benefits:

- In-depth understanding of diagnostic deal trends since 2007

- Analysis of the structure of diagnostic agreements with numerous real life case studies

- Comprehensive access to over 2,900 actual diagnostic contracts entered into by the world's biopharma companies

- Detailed access to actual diagnostic contracts enter into by the leading fifty bigpharma companies

- Insight into the terms included in a diagnostic agreement, together with real world clause examples

- Understand the key deal terms companies have agreed in previous deals

- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in diagnostic dealmaking

Chapter 3 - Leading diagnostic deals

Chapter 4 - Bigpharma diagnostic deals

Chapter 5 - Diagnostic dealmaking directory

Chapter 6 - Diagnostic partnering resource center

Appendices

Appendix

About Current Partnering

Table of figures

For more information visit http://www.researchandmarkets.com/research/ns5h26/diagnostics